Improving safety practices for children treated with antipsychotic medications
Advancing Patient Safety for Antipsychotic-Treated Children: Examining State Implementation of Safe Use Practices
This study is looking at ways to make sure that children on Medicaid who take antipsychotic medications are using them safely, by checking how different state programs help monitor their health and reduce the use of multiple medications, so that doctors and policymakers can learn what works best for kids' health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10456732 on NIH RePORTER |
What this research studies
This research focuses on enhancing the safety of antipsychotic medication use among children enrolled in Medicaid. It aims to identify and evaluate state-level initiatives that promote safe use practices, such as monitoring health metrics and minimizing the use of multiple antipsychotic medications. By employing a mixed-methods approach, the project will assess the effectiveness of these initiatives and disseminate findings to inform healthcare providers and policymakers. The ultimate goal is to improve health outcomes for children receiving antipsychotic treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are children enrolled in Medicaid who are being treated with antipsychotic medications.
Not a fit: Patients not receiving antipsychotic medications or those outside the Medicaid system may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer treatment practices for children on antipsychotic medications, reducing the risk of serious health complications.
How similar studies have performed: Previous projects have shown that implementing safety guidelines can improve treatment practices, suggesting potential for success in this research.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Crystal, Stephen — Rutgers, the State Univ of N.j.
- Study coordinator: Crystal, Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.